Toshio Tabei

1.4k total citations
65 papers, 948 citations indexed

About

Toshio Tabei is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Toshio Tabei has authored 65 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 29 papers in Cancer Research and 17 papers in Pathology and Forensic Medicine. Recurrent topics in Toshio Tabei's work include Cancer Treatment and Pharmacology (29 papers), Breast Cancer Treatment Studies (28 papers) and Breast Lesions and Carcinomas (16 papers). Toshio Tabei is often cited by papers focused on Cancer Treatment and Pharmacology (29 papers), Breast Cancer Treatment Studies (28 papers) and Breast Lesions and Carcinomas (16 papers). Toshio Tabei collaborates with scholars based in Japan, United States and Switzerland. Toshio Tabei's co-authors include Kenichi Inoue, Masafumi Kurosumi, Hiroyuki Takei, Kimito Suemasu, Jun Ninomiya, Yuji Hayashi, Takashi Yoshida, Kenjiro Aogi, Carlos H. Barrios and Hiroji Iwata and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Agricultural and Food Chemistry.

In The Last Decade

Toshio Tabei

64 papers receiving 916 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toshio Tabei Japan 19 547 448 195 141 132 65 948
Takao Yokoe Japan 18 544 1.0× 317 0.7× 206 1.1× 200 1.4× 182 1.4× 104 1.1k
Antonio Rulli Italy 16 382 0.7× 371 0.8× 293 1.5× 213 1.5× 351 2.7× 40 1.0k
Dilani Lokuhetty Sri Lanka 6 305 0.6× 278 0.6× 228 1.2× 122 0.9× 118 0.9× 19 873
Won Ho Kil South Korea 17 364 0.7× 360 0.8× 175 0.9× 156 1.1× 101 0.8× 44 761
Sei‐Hyun Ahn South Korea 20 305 0.6× 423 0.9× 156 0.8× 231 1.6× 267 2.0× 56 948
R.E. Mansel United Kingdom 20 414 0.8× 489 1.1× 426 2.2× 234 1.7× 246 1.9× 70 1.2k
Fabio Bassi Italy 17 515 0.9× 615 1.4× 306 1.6× 304 2.2× 393 3.0× 45 1.4k
Xiaoming Zha China 17 290 0.5× 287 0.6× 175 0.9× 251 1.8× 139 1.1× 58 902
Ninah Achacoso United States 19 456 0.8× 331 0.7× 122 0.6× 245 1.7× 76 0.6× 49 808
Denis Evoy Ireland 18 476 0.9× 507 1.1× 340 1.7× 391 2.8× 304 2.3× 49 1.3k

Countries citing papers authored by Toshio Tabei

Since Specialization
Citations

This map shows the geographic impact of Toshio Tabei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshio Tabei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshio Tabei more than expected).

Fields of papers citing papers by Toshio Tabei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshio Tabei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshio Tabei. The network helps show where Toshio Tabei may publish in the future.

Co-authorship network of co-authors of Toshio Tabei

This figure shows the co-authorship network connecting the top 25 collaborators of Toshio Tabei. A scholar is included among the top collaborators of Toshio Tabei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshio Tabei. Toshio Tabei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inaji, Hideo, Hiroji Iwata, Takahiro Nakayama, et al.. (2012). Randomized phase II study of three doses of oral TAS‐108 in postmenopausal patients with metastatic breast cancer. Cancer Science. 103(9). 1708–1713. 6 indexed citations
2.
Kaptein, Adrian A., Kazue Yamaoka, Lucia Snoei, et al.. (2012). Illness Perceptions and Quality of Life in Japanese and Dutch Women with Breast Cancer. Journal of Psychosocial Oncology. 31(1). 83–102. 32 indexed citations
3.
Hayashi, Yuji, Hiroyuki Takei, Akihiro Ichikawa, et al.. (2012). Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer. Oncology Letters. 5(1). 83–89. 56 indexed citations
4.
Kurosumi, Masafumi, Yasuhito Kobayashi, Hiroyuki Takei, et al.. (2011). Pathological tumor response to neoadjuvant chemotherapy using anthracycline and taxanes in patients with triple-negative breast cancer. Experimental and Therapeutic Medicine. 2(2). 257–264. 20 indexed citations
5.
Barrios, Carlos H., Mei-Ching Liu, Soo Chin Lee, et al.. (2010). Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer. Breast Cancer Research and Treatment. 121(1). 121–131. 163 indexed citations
6.
Takei, Hiroyuki, Masafumi Kurosumi, Takashi Yoshida, et al.. (2010). Neoadjuvant endocrine therapy of breast cancer: which patients would benefit and what are the advantages?. Breast Cancer. 18(2). 85–91. 18 indexed citations
7.
Takei, Hiroyuki, Masafumi Kurosumi, Takashi Yoshida, et al.. (2009). Positive sentinel lymph node biopsy predicts the number of metastatic axillary nodes of breast cancer. The Breast. 18(4). 244–247. 4 indexed citations
8.
Yoshida, Takashi, Hiroyuki Takei, Masafumi Kurosumi, et al.. (2009). True Recurrences and New Primary Tumors Have Different Clinical Features in Invasive Breast Cancer Patients with Ipsilateral Breast Tumor Relapse After Breast-Conserving Treatment. The Breast Journal. 16(2). 127–133. 18 indexed citations
9.
10.
Kusama, M., Tadashi Nomizu, Kenjiro Aogi, et al.. (2009). Phase II study of 4-weekly capecitabine monotherapy in advanced/metastatic breast cancer. Breast Cancer. 17(4). 233–240. 17 indexed citations
11.
Takei, Hiroyuki, Masafumi Kurosumi, Takashi Yoshida, et al.. (2007). Current trends of sentinel lymph node biopsy for breast cancer —A surgeon’s perspective. Breast Cancer. 14(4). 362–370. 20 indexed citations
12.
Takei, Hiroyuki, Kimito Suemasu, Masafumi Kurosumi, et al.. (2006). 99mTc-Phytate Is Better than 99mTc-Human Serum Albumin as a Radioactive Tracer for Sentinel Lymph Node Biopsy in Breast Cancer. Surgery Today. 36(3). 219–224. 21 indexed citations
13.
Saeki, Toshiaki, Shigemitsu Takashima, Masami Ogita, et al.. (2006). Efficacy and toxicity of vinorelbine with doxorubicin/cyclophosphamide combination chemotherapy in a phase I-II study for advanced or recurrent breast cancer patients. Breast Cancer. 13(2). 159–165. 2 indexed citations
14.
Takei, Hiroyuki, Kimito Suemasu, Masafumi Kurosumi, et al.. (2006). Added value of the presence of blue nodes or hot nodes in sentinel lymph node biopsy of breast cancer. Breast Cancer. 13(2). 179–185. 22 indexed citations
15.
Aihara, Tomohiko, Yuichi Takatsuka, Kuniaki Itoh, et al.. (2003). Phase II Study of Concurrent Administration of Doxorubicin and Docetaxel as First-Line Chemotherapy for Metastatic Breast Cancer. Oncology. 64(2). 124–130. 10 indexed citations
16.
Tominaga, T., I Adachi, Yo Sasaki, et al.. (2002). Double-blind randomised trial comparing the non-steroidal aromatase inhibitors letrozole and fadrozole in postmenopausal women with advanced breast cancer. Annals of Oncology. 14(1). 62–70. 31 indexed citations
17.
Ito, Yoshinori, N Horikoshi, Toru Watanabe, et al.. (1998). Phase II study of paclitaxel (BMS-181339) intravenously infused over 3 hours for advanced or metastatic breast cancer in Japan. Investigational New Drugs. 16(2). 183–190. 15 indexed citations
18.
19.
Takashima, Shigemitsu, Toshiaki Saeki, I Adachi, et al.. (1997). A Phase II Study of High-Dose Epirubicin (EPI) Plus Cyclophosphamide (CPA) With G-CSF for Breast Cancer Patients With Visceral Metastases or Hormone-Independent Tumors: A Trial of the Japan Clinical Oncology Group. Japanese Journal of Clinical Oncology. 27(5). 325–330. 4 indexed citations
20.
Tabei, Toshio, et al.. (1978). Clinical Evaluation of Tumor Scintigraphy with 201Tl-chloride. RADIOISOTOPES. 27(8). 477–480. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takao Yokoe Breakdown of academic impact, for papers by Antonio Rulli Breakdown of academic impact, for papers by Dilani Lokuhetty Breakdown of academic impact, for papers by Won Ho Kil Breakdown of academic impact, for papers by Sei‐Hyun Ahn Breakdown of academic impact, for papers by R.E. Mansel Breakdown of academic impact, for papers by Fabio Bassi Breakdown of academic impact, for papers by Xiaoming Zha Breakdown of academic impact, for papers by Ninah Achacoso Breakdown of academic impact, for papers by Denis Evoy
Rankless by CCL
2026